AOD-9604

DISCLAIMER: We do not supply peptides to Any individual under the age of 18. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals is committed to providing an extensive range of products used in the process of medical research by responsible trained and professional individuals. All products listed on this website and provided through Supotropin Lab are intended for medical research purposes only. Supotropin Lab does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended to be used as a drug, stimulant, or for use in any food products.

AOD-9604

AOD stands for Anti-Obesity. Studies have shown this peptide AOD-9604 is used in the treatment of obesity. Facilitates the rapid burning of fats and the development of muscles. Research has shown that AOD-9604 is the first peptide of its kind.

AOD-9604 has been shown by studies to work for people who are dealing with obesity. Not only help to improve metabolism but also to build muscle. The bodies of obese people may have trouble burning fat. AOD-9604 has been shown to mimic the hormone which stimulates fat metabolism, promoting a faster loss of weight by improving metabolism. It enhances the functioning of beta-3 receptors.

This makes it different from other medications that treat obesity. Other medications suppress appetite or the rate of food absorption. This peptide has been shown in studies used on rats to have a high capacity to burn fat. It triggers the release of fats from the fat cells which leads to obesity. Especially great in reducing stubborn fats in the abdominal area.

Additionally, studies have shown that this peptide can help treat osteoarthritis by enhancing cartilage and bone repair. According to the researchers, the injection of AOD-9604 straight into arthritic joints has improved quality of life, alleviating pain, and reducing disability in rats. In addition, joint dysfunction appears to be reduced by using AOD 9604 therapy, according to clinical trials.